Skip to main content
Actas Españolas de Psiquiatría logoLink to Actas Españolas de Psiquiatría
. 2026 Jun 15;54(3):891–906. doi: 10.62641/aep.v54i3.2198

Impact of Structured Physical Exercise Programs (SPEs) on Symptoms and Clinical Outcomes in Schizophrenia: A Systematic Review With Qualitative Synthesis of Randomized Controlled Trials (2015–2025)

Gustavo Baroni Araujo 1,*, Carolina Alves de Moraes Nicolau 1, Bruno Marson Maladogi 2, Sionaldo Eduardo Ferreira 3, Christian José dos Santos 4, Helio Serassuelo Junior 2,*
PMCID: PMC13294849  PMID: 42343729

Abstract

Background:

People with schizophrenia present persistent deficits that are poorly responsive to pharmacological treatment, particularly including negative symptoms and cognition. Recent evidence indicates that structured physical exercise programs (SPEs) can modulate relevant neurobiological mechanisms and improve essential clinical outcomes. Given the heterogeneity of existing protocols, a systematic synthesis of this evidence is necessary. The aim of this study was to investigate the effects of SPEs on symptomatology, cognition, global functioning, and physical fitness in individuals with schizophrenia.

Methods:

A systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, with searches conducted in the PubMed/Medline, Scopus, Web of Science, Cochrane Central Register of Controlled Trials (CENTRAL), Scientific Electronic Library Online (SciELO), Latin American and Caribbean Health Sciences Literature (LILACS), and Virtual Health Library (VHL) databases. Randomized clinical trials with adults diagnosed with schizophrenia who underwent structured exercise interventions were included. Initial searches identified 756 records, of which 16 studies were included in the review and comprised the final synthesis. Data extraction followed a standardized form, and study characteristics are described using descriptive statistics.

Results:

The included trials demonstrated consistent effects of different categories of physical exercise on negative symptoms, general symptoms, and overall functioning related to physical fitness, as well as improvements in cognitive aspects. A variety of SPE protocols were observed, as well as different intensities and instruments for evaluating the effectiveness of the interventions. Regarding intensity, it was noted that low-intensity SPEs also produced benefits, especially in institutionalized contexts; however, the metabolic effects were less consistent. Furthermore, the heterogeneity of the protocols influenced the magnitude of the results.

Conclusions:

SPEs generate positive clinical impacts that are adaptable to the needs of each patient, an essential aspect given the common barriers observed in the diagnosis of schizophrenia. The findings support the integration of SPEs into mental health services, as a component capable of expanding clinical and functional outcomes, and offering an accessible intervention aligned with the needs of this population.

Keywords: schizophrenia, exercise, physical fitness, cognition, qualitative synthesis, randomized controlled trials

Introduction

Schizophrenia remains one of the most disabling psychiatric disorders, not only because of the presence of positive psychotic symptoms but also due to the persistence of negative symptoms and cognitive deficits that permanently compromise the social and occupational functioning and autonomy of affected individuals [1]. Robust evidence demonstrates that these symptomatic domains are more strongly associated with functional outcomes and quality of life than the positive symptoms themselves, thus constituting priority therapeutic targets that have historically been neglected in clinical practice [2].

Although antipsychotic medications represent the cornerstone of schizophrenia treatment, their effectiveness presents well-recognized limitations. Meta-analyses indicate that these drugs primarily reduce positive symptoms, while their effects on negative symptoms and cognitive deficits are generally modest and often insufficient to produce meaningful functional recovery [3, 4]. In addition, long-term pharmacological treatment is frequently associated with metabolic and cardiovascular side effects that contribute to reduced physical fitness and an increased risk of morbidity and mortality in this population [5]. These limitations highlight the importance of complementary non-pharmacological strategies that are able to address broader clinical and functional dimensions of the disorder.

For the purposes of the current review, structured physical exercise programs (SPEs) are defined as planned, structured, repetitive, and purposeful physical activities, aimed at improving or maintaining physical fitness components, such as cardiorespiratory capacity, muscular strength, and endurance. This definition is consistent with widely adopted conceptual frameworks in exercise science and public health literature, which distinguish physical exercise from general physical activity based on its systematic and goal-oriented nature [6]. Physical exercise promotes widely documented physiological and neurobiological adaptations, including increased cardiorespiratory fitness, modulation of dopaminergic and glutamatergic systems, enhancement of neuroplasticity, and reduction in systemic inflammatory processes, mechanisms closely related to the pathophysiology of schizophrenia [7].

Over the past decade, several randomized clinical trials have investigated the effects of different exercise modalities on psychiatric symptoms, cognitive functioning, physical fitness, and other clinically relevant outcomes in individuals with schizophrenia. Previous systematic reviews and meta-analyses suggest that exercise-based interventions may improve negative symptoms, cognitive performance, and global functioning, in addition to producing benefits for physical health indicators [8, 9, 10]. However, considerable heterogeneity exists among intervention protocols, including differences in exercise modality, intensity, duration, supervision, and outcome measures, which makes direct comparisons between studies challenging.

Furthermore, many previous reviews combine evidence from studies with heterogeneous designs, including observational studies and uncontrolled interventions, which may limit their ability to establish robust causal inferences regarding the therapeutic effects of exercise in schizophrenia [11, 12]. In this sense, analyses that focus exclusively on randomized clinical trials are essential to provide a more rigorous synthesis of the available evidence on the clinical effects of structured exercise interventions.

Given this scenario, there is a need to critically organize the available evidence derived from randomized clinical trials, in order to better understand the extent to which physical exercise interventions influence psychiatric symptoms, cognition, physical fitness, and other clinical indicators of schizophrenia. Such an approach allows not only evaluation of the magnitude and consistency of reported effects but also identification of methodological gaps and directions for future research.

Therefore, the aim of the current study was to systematically synthesize the evidence from randomized clinical trials that investigated structured physical exercise programs in people with schizophrenia, to evaluate their effects on psychiatric symptoms and other relevant clinical outcomes, as well as identify response patterns associated with different exercise modalities and intervention protocols.

Materials and Methods

Study Design

This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) guidelines [12], ensuring methodological rigor and transparency throughout all stages of the review.

Research Question and Eligibility Criteria

The research question was structured according to the Population, Intervention, Comparison, and Outcomes (PICO) model. The Population (P) included adults (≥18 years) diagnosed with schizophrenia based on Diagnostic and Statistical Manual of Mental Disorders (DSM) or International Classification of Diseases (ICD) criteria, or explicit clinical diagnostic descriptions. Studies including mixed-age populations were only considered if data for adult participants were reported separately. The Intervention (I) consisted of structured physical exercise programs, supervised or unsupervised, including aerobic training, resistance training, high-intensity interval training (HIIT), combined exercise protocols, or other structured physical activity interventions described in the trials. The Comparison (C) included usual care, waiting list conditions, non-exercise interventions, or comparisons between different exercise modalities and intensities. Outcomes (O) comprised changes in psychiatric symptoms (positive, negative, and general symptoms) as well as additional clinical outcomes, such as cognition, physical fitness, functioning, and biological markers, assessed through validated instruments. The Study type (S) was restricted to randomized controlled trials (RCTs).

Eligibility criteria were defined a priori to ensure methodological transparency and reduce potential selection bias. Studies were included if they met the following criteria: (1) RCTs published in peer-reviewed journals; (2) studies involving adults (≥18 years) diagnosed with schizophrenia or schizophrenia spectrum disorders, or studies with mixed-age samples, provided that results for adult participants were reported separately; (3) investigations evaluating structured physical exercise interventions with clearly described protocols, including information on frequency, duration, intensity, or modality of exercise; and (4) studies reporting at least one clinical outcome related to psychiatric symptoms, cognitive performance, physical fitness, global functioning, or other relevant health indicators.

Studies were excluded if they met any of the following criteria: (1) observational studies, quasi-experimental designs, case reports, reviews, study protocols, theses, or dissertations; (2) studies involving mixed psychiatric populations without separate analysis for participants with schizophrenia; (3) studies evaluating general physical activity or lifestyle interventions without a structured exercise protocol; or (4) studies that did not report post-intervention clinical outcomes.

Search Strategy

The systematic search was conducted in the PubMed/Medline, Scopus, Web of Science, Cochrane Central Register of Controlled Trials (CENTRAL), Scientific Electronic Library Online (SciELO), Latin American and Caribbean Health Sciences Literature (LILACS), and Virtual Health Library (VHL) databases. These databases were selected due to their broad coverage of psychiatry, neuroscience, and exercise science literature.

The search period covered studies published between January 2015 and September 2025 in order to capture recent and methodologically relevant evidence. Controlled descriptors Medical Subject Headings/Health Sciences Descriptors (MeSH/DeCS) and free-text terms related to “schizophrenia,” “exercise,” “physical activity,” and “randomized controlled trial” were combined using Boolean operators (AND/OR). Database-specific adaptations were applied when necessary. When available, filters for human participants, adults, and RCTs were used.

Study Selection

All records retrieved from the databases were imported into the Zotero reference manager, where duplicate records were removed using automated detection followed by manual verification. Study selection was conducted in two stages; first, titles and abstracts were screened independently by two reviewers, then second, the full texts of potentially eligible studies were assessed. Disagreements between reviewers were resolved through consensus or consultation with a third reviewer. Reasons for exclusion during the full-text stage were recorded.

Data Extraction

Data extraction was performed independently by two reviewers using a standardized data extraction form. The information collected included author and year, country, study design, sample characteristics, diagnostic criteria, clinical setting (outpatient, community, or inpatient), characteristics of the intervention (exercise modality, frequency, duration, and intensity when reported), type of comparator group, instruments used to assess outcomes, and main clinical outcomes. When available, additional information regarding adherence rates, participant dropouts, and adverse events was also extracted.

Risk of Bias Assessment

The risk of bias of the included studies was assessed using the Cochrane Risk of Bias 2.0 (RoB 2) tool [13, 14]. This instrument assesses domains related to the randomization process, deviations from intended interventions, missing outcome data, outcome measurements, and selection of reported results. The risk of bias assessments were incorporated into the critical interpretation of the findings.

Data Synthesis

Due to the considerable heterogeneity among the included studies in terms of exercise modality (e.g., aerobic training, resistance training, HIIT, Tai Chi, and combined exercise programs), intervention intensity, duration, clinical settings (outpatient versus institutionalized populations), and outcome assessment instruments, a quantitative meta-analysis was not considered methodologically appropriate. In addition, the trials evaluated different outcome domains using heterogeneous measurement tools (e.g., Positive and Negative Syndrome Scale (PANSS), Brief Psychiatric Rating Scale (BPRS), MATRICS Consensus Cognitive Battery (MCCB), maximal oxygen consumption (VO2 max), functional scales, and biological markers), which limited the possibility of calculating and pooling comparable effect sizes across studies. Conducting a meta-analysis under such conditions could lead to misleading statistical aggregation and compromise the interpretability of the results.

Therefore, the synthesis of results was conducted qualitatively. The findings were organized according to major outcome domains, including positive symptoms, negative symptoms, general psychopathology, cognitive outcomes, functional outcomes, and physiological variables.

To improve interpretability of comparisons, control conditions were categorized into three types: (1) usual care or treatment as usual (TAU); (2) passive controls, such as waiting list conditions; and (3) active non-exercise interventions (e.g., psychoeducation, cognitive training, or active video games). This stratification allows clearer interpretations of intervention effects, since comparisons with passive controls tend to produce larger effect sizes than those involving active interventions.

For descriptive purposes, measures of central tendency and dispersion were calculated for selected study characteristics. The median (Md) and interquartile range (IQR) were used to summarize variables, including sample size, number of participants per group, and intervention duration. These descriptive statistics were used solely to characterize the included studies and not for inferential comparisons between trials. The final selection of studies is presented in the PRISMA flow diagram (Fig. 1).

Fig. 1.

Fig. 1.

Flowchart of the process adopted to identify, select, determine eligibility, and include studies in the systematic review. RCT, randomized controlled trial. Source: Prepared by the authors.

Results

The included studies were organized to provide a clear and integrated overview of the methodological, sampling, and clinical characteristics of the analyzed trials. Initially, a detailed characterization of the studies was carried out, including the country where the studies were conducted, type of physical exercise intervention, clinical context of the participants (outpatient, community, or hospital), duration of the programs, and number of participants per group. Table 1 (Ref. [8, 9, 10, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27]) summarizes this information, allowing a general overview of the samples and experimental protocols.

Table 1.

Characteristics of the RCTs included in the systematic review: author, clinical setting, country, intervention duration, and sample size (total and per group).

Author (year) Clinical setting Country Intervention duration (weeks) Sample size Number of participants in the experimental group (EG) Number of participants in the control group (CG)
Silva et al. [8] outpatient Brazil 20 34 21 (RESEX, n = 12 + CONCEX, n = 9) 13
Curcic et al. [9] institutionalized Serbia 12 80 40 40
Brobakken et al. [10] outpatient Norway 12 48 25 23
Maurus et al. [15] outpatient and institutionalized Germany 12 15 7 8
Ho et al. [16] institutionalized China 12 153 102 (Tai Chi + exercise) 51 (wait-list control)
Tous-Espelosin et al. [17] outpatient Spain 20 112 59 53
Andersen et al. [18] outpatient Norway 12 82 41 41
Bang-Kittilsen et al. [19] outpatient Norway 12 82 43 39
Kurebayashi et al. [20] institutionalized Japan 8 22 5 17
Wang et al. [21] outpatient Taiwan 12 62 33 29
Kimhy et al. [22] outpatient United States 12 33 16 17
Cheng et al. [23] outpatient Taiwan 8 54 26 28
Ryu et al. [24] outpatient South Korea 16 60 30 30
Lo et al. [25] outpatient China 12 51 17 18
Shimada et al. [26] outpatient Japan 12 31 16 15
Khonsari et al. [27] outpatient Iran 8 40 20 20

Note: EG, experimental group; CG, control group; RESEX, resistance exercise; CONCEX, concurrent exercise; outpatient, participants receiving outpatient care; institutionalized, inpatient or hospitalized participants; wait-list control, participants receiving standard care while awaiting intervention; usual care, standard psychiatric treatment without structured physical exercise; RCTs, randomized controlled trials.

Descriptive analyses of the methodological characteristics of the included studies revealed a remarkable consistency in the duration of the interventions, with a median of 12 weeks (IQR = 12), adopted in 10 (62.5%) of the sixteen trials. The total sample size varied widely, ranging from 15 to 153 participants (Md = 52; IQR = 47), reflecting the coexistence of pilot trials and larger studies. The experimental groups had a median of 25 participants (IQR = 24), while the control groups exhibited an equivalent median (Md = 25; IQR = 22), indicating a general balance between the conditions compared.

The mean number of participants per study was 59, evidencing moderate sample sizes in most trials. Taken together, these data demonstrate heterogeneity in sample size, but methodological uniformity regarding the duration of the interventions, which were mostly concentrated in short-term to medium-term physical exercise programs.

Table 2 (Ref. [8, 9, 10, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27]) describes the exposure variables related to the physical exercise programs: category of physical exercise or modality, weekly frequency (days), session duration (minutes), intensity (when reported), and type of treatment received by the control group (CG) or comparison with other modalities.

Table 2.

Characteristics of structured physical exercise interventions and control conditions in the included RCTs.

Description of the exposure variable(s)
Author (year) EG CG
exercise modality frequency (sessions/ week) session duration (minutes) intensity treatment
Silva et al. [8] RESEX (resistance) and CONCEX (concurrent training) 3 60 60–80% 1RM (endurance); moderate 60–70% HRmax (aerobic) usual outpatient treatment (without exercise)
Curcic et al. [9] prescribed physical activity program (aerobic exercise) 4 45 moderate (65–75% HRmax) conventional treatment, hospitalized (inpatient) patients
Brobakken et al. [10] AIT 2 30–40 high intensity interval training 2 initial AIT sessions + encouragement for autonomous exercise—without regular supervised training.
Maurus et al. [15] resistance training 3 50 moderate-vigorous body balance and toning program (active control)
Ho et al. [16] Tai Chi/moderate physical exercise 3 45–60 moderate wait-list control + standard institutional rehabilitation care (medication and usual treatment)
Tous-Espelosin et al. [17] combined workout: low-volume HIIT + resistance circuit 3 30–45 low-volume HIIT (<10 min of high-intensity time per session) and resistance usual outpatient treatment
Andersen et al. [18] HIIT 2 30–40 high intensity (high effort intervals on the treadmill) outpatients with schizophrenia in usual treatment; computer gaming skills training (active control for social/sedentary engagement)
Bang-Kittilsen et al. [19] HIIT on a treadmill (EG) and active video games (Nintendo Wii Sports: bowling, golf, tennis (CG) 2 45 EG: 8 min warm-up; 4 × 4 min at 85–95% HRmax with 3 min active recovery at 70% HRmax; 5 min cool-down; CG: low to moderate (free body movements, no specific HR target) from psychiatric outpatient follow-up
Kurebayashi et al. [20] low-intensity physical exercise 3 30–45 light typical treatment for psychiatric hospitalization (pharmacotherapy + inpatient care), without structured exercise
Wang et al. [21] AE 3 30–45 moderate-vigorous patients receiving antipsychotics, usual community treatment.
Kimhy et al [22] aerobic exercise (active-play video games + equipment AE) 3 30–45 moderate-vigorous aerobic (measured by VO2peak ) TAU (outpatient psychiatric care, no exercise)
Cheng et al. [23] aerobic dance program 3 30–60 moderate without intervention, usual outpatient care
Ryu et al. [24] outdoor cycling 1 90 moderate weekly occupational therapy (daily living skills)—without structured physical exercise
Lo et al. [25] EG: HIIT; EC: psychoeducation without structured exercise 3 30–45 high intensity (HIIT protocol) psychoeducation and usual treatment
Shimada et al. [26] aerobic exercise (individual + group) 2 30–45 moderate patients seen in outpatient services and maintaining usual psychiatric treatment.
Khonsari et al. [27] aerobic exercise (multi-session program) 3 30–45 self-managed pharmacological treatment (no exercise)

Note: EG, experimental group; CG, control group; AE, aerobic exercise; AIT, aerobic interval training; HIIT, high-intensity interval training; HRmax, maximum heart rate; 1RM, one-repetition maximum; TAU, treatment as usual; active control, structured non-exercise intervention; passive control, waiting list or no intervention condition; RCTs, randomized controlled trials; VO2peak, peak oxygen consumption; HR, heart rate.

Physical exercise interventions showed great diversity in terms of the modalities, intensities, and training structures used in clinical trials. Traditional aerobic interventions predominated [8, 10, 21, 22, 23], although some studies employed specific modalities, such as resistance training [8, 15], Tai Chi [16], and mixed programs involving low-volume HIIT combined with resistance circuits [17].

Weekly training frequency ranged from one to four sessions, with a predominance of three sessions per week, while the duration of the sessions ranged from 30 to 90 minutes, with an approximate median of 40–45 minutes. Regarding intensity, most interventions focused on moderate to vigorous intensity efforts, frequently monitored by physiological parameters such as percentage of maximum heart rate (typically 60–80% maximum heart rate (HRmax) or equivalent measures).

Notably, some studies adopted very high intensity protocols, especially those based on HIIT or aerobic interval training (AIT) [10, 18, 19, 25], while others used light exercise, such as low-intensity protocols [20]. The control groups were heterogeneous, varying between usual treatment without exercise [8, 21, 23], waiting lists [16], active non-physical interventions (psychoeducation, cognitive training, active video games) [18, 19, 25], or alternative programs of unstructured physical activity [9, 24].

The synthesis of clinical outcomes assessed by randomized clinical trials reveals consistent effects of physical exercise on multiple domains of schizophrenia (Table 3, Ref. [8, 9, 10, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27]). Most studies that used standardized psychopathological scales demonstrated significant reductions in general symptoms and, especially, in negative symptoms, with aerobic and HIIT protocols standing out [8, 9, 16, 21, 24]. Trials that included measures of cardiorespiratory fitness (VO2max or peak oxygen consumption (VO2peak)) reported significant improvements in aerobic capacity, often greater than those observed in control groups [10, 17, 23, 25].

Table 3.

Outcome measures and main post-intervention findings of the included RCTs.

Author (year) Measures, instrument(s) and variables analyzed Main clinical outcome(s) post-intervention
Silva et al. [8] PANSS Significant reduction in total PANSS symptoms and positive symptoms, and improvement in negative symptoms in RESEX.
SF-36, “role-physical” domain Improvement in the “role-physical” domain of the SF-36 in the endurance group.
Muscle strength tests (1RM arm extension, bench press) Increase in muscle strength (1RM) in upper limbs.
Serum markers: BDNF, IGF-1, IGFBP-3 No significant changes in BDNF, IGF-1, and IGFBP-3.
Curcic et al. [9] PANSS—positive and negative symptoms and general psychopathology Significant increase in VO2max in the EG after 12 weeks vs. control.
Cardiopulmonary exercise test (VO2max) Significant improvement in global symptoms and in the general psychopathology subscale of the PANSS in the EG.
Significant reduction in the total PANSS score in the EG compared to the CG.
Indicative that prescribed physical activity can alleviate clinical symptoms of schizophrenia when added to usual treatment.
Brobakken et al. [10] VO2peak Significant improvement in VO2peak in the EG compared to the CG after 12 weeks.
Cardiometabolic measurements: weight, BMI, waist circumference, blood pressure, lipids, and glucose No significant differences between groups in weight, BMI, waist circumference, blood pressure, lipids, or glucose in the post-test.
Weight gain and BMI in the CG group vs. stability in the TG group.
Maurus et al. [15] WHO-DAS 2.0, GAF, general and physical functioning measures No significant difference in WHO-DAS (primary outcome).
Significant improvement in GAF over time, more marked in the resistance group.
Safe and feasible intervention.
Good adherence, with no relevant adverse events.
Ho et al. [16] Standardized psychiatric interviews (psychiatric status scales for psychotic, negative, and depressive symptoms) Both groups (Tai Chi and physical exercise) showed a reduction in motor deficits compared to the CG.
Self-report questionnaires Tai Chi: increased working memory (backward digit span) and increased average cortisol.
Performance tasks (e.g., forward and reverse digit span for memory) Exercise: reduction in negative and depressive symptoms, improved memory (forward digit span) and function in activities of daily living, in addition to an increase in average cortisol.
Measures of motor coordination Both intervention groups presented fewer symptoms than the CG, with the exercise group showing better symptom management than the Tai Chi group.
Salivary cortisol (average)
Tous-Espelosin et al. [17] Maximum cardiopulmonary exercise test on a cycle ergometer (VO2peak); body composition measurements; biochemical markers. Significant increase in cardiorespiratory fitness (VO2peak, ventilatory threshold, peak HR) in the exercise group.
Maintenance of body composition; no significant changes in TAU.
Andersen et al. [18] VO2max (measured directly on a treadmill) No significant difference between HIIT and control in VO2max at the end of 12 weeks.
ActiGraph accelerometer (physical activity level) No significant change in overall physical activity level or body composition between the groups.
Bioelectrical impedance (body composition: weight, BMI, fat) Increased workload on the treadmill was observed in HIIT.
Approximately 47% of HIIT participants had a ≥5% increase in VO2max (individual clinical response).
Bang-Kittilsen et al. [19] PANSS (5-factor model); CDSS; VO2max (cardiopulmonary exercise test) HIIT increased VO2max and reduced depressive symptoms (CDSS) and specific components of the PANSS compared to active video games.
Effects maintained in a 4-month follow-up.
Kurebayashi et al. [20] Scale of psychiatric symptoms After statistical adjustments (negative symptoms + days of hospitalization), the light exercise group showed a significant improvement in overall neurocognition compared to the CG.
Global neurocognitive assessment (neuropsychological battery) The authors suggest that light exercise may accelerate recovery and allow for earlier discharge.
Length of hospitalization (days)
Wang et al. [21] PANSS Significant reduction in negative symptoms and general psychopathology in the AE group vs. CG.
Improvement in positive symptoms during 12 weeks in the AE group.
Greater reduction in overall condition severity.
Effects partially maintained up to 3 months of follow-up (for negative symptoms).
Kimhy et al [22] Cardiorespiratory fitness test (VO2peak, mL/kg/min) Significant improvement in aerobic fitness in the exercise group (+18% in VO2peak) vs. small decline in TAU.
MCCB–neurocognitive composite score Improvement in overall neurocognitive function (MCCB: +15.1%) vs. worsening in the CG (-2.0%).
Serum BDNF level Increase in serum BDNF, and changes in VO2 and BDNF predicting part of the cognitive improvement.
Cheng et al. [23] Body weight Significant reduction in weight and BMI in the EG.
BMI Significant improvement in flexibility.
Flexibility Improved cardiorespiratory fitness at the end of 8 weeks.
Muscular endurance Improved muscle endurance in the immediate post-test.
Cardiorespiratory endurance Fitness effects maintained in the follow-up.
Ryu et al. [24] BPRS Significant improvement in psychotic symptoms (BPRS) in the cycling group vs. CG.
BDI Reduction in depression, state anxiety, and trait anxiety in the cycling group.
STAI Improvement in overall functioning (GAF) in the EG.
RSES Improvement in executive function (accuracies and categories in the WCST).
GAF Significant increase in objectively measured physical activity (pedometer—steps/day).
WCST No difference in the total K-PASE score, but there was a difference in objectively measured daily steps.
Physical Activity Scale (K-PASE)
Pedometer (steps/day)
Lo et al. [25] MST for sleep-dependent procedural memory consolidation; measures of cognitive performance and sleep (described in more detail in the full article) HIIT and AE improved sleep-dependent procedural memory (SDM) consolidation compared to psychoeducation, with a more robust effect for HIIT.
Shimada et al. [26] Standardized measures of cognitive performance Significant improvement in overall cognitive function in the TAU + AE group compared to TAU alone after 12 weeks.
General cognitive function questionnaires AE showed a trend toward improvement in domains such as attention, working memory, and processing speed (greater effects in the EG).
Khonsari et al. [27] PANSS (5-factor model); CDSS; VO2max (cardiopulmonary exercise test) HIIT increased VO2max and reduced depressive symptoms (CDSS) and specific components of the PANSS compared to active video games.
Effects were maintained at the 4-month follow-up.

Note: PANSS, Positive and Negative Syndrome Scale; SF-36, Short Form Health Survey (36 items); 1RM, one-repetition maximum; BDNF, brain-derived neurotrophic factor; IGF-1, insulin-like growth factor 1; IGFBP-3, insulin-like growth factor binding protein 3; VO2peak/VO2max, peak/maximal oxygen consumption; peak HR, peak heart rate; MCCB, MATRICS Consensus Cognitive Battery; BPRS, Brief Psychiatric Rating Scale; BDI, Beck Depression Inventory; STAI, State-Trait Anxiety Inventory; RSES, Rosenberg Self-Esteem Scale; GAF, Global Assessment of Functioning; WCST, Wisconsin Card Sorting Test; K-PASE, Korean version of the Physical Activity Scale for the Elderly; CDSS, Calgary Depression Scale for Schizophrenia; MST, motor sequence task; WHO-DAS 2.0, World Health Organization Disability Assessment Schedule 2.0.; CG, control group; EG, experimental group; AE, aerobic exercise; HIIT, high-intensity interval training; RCTs, randomized controlled trials; BMI, body mass index; TAU, treatment as usual.

Furthermore, cognitive benefits were also recurrent, especially in executive functions, processing speed, working memory, and sleep-dependent memory consolidation, particularly in interventions involving aerobic exercise or HIIT [22, 24, 25, 26]. Studies that assessed functional markers and measures of global functioning (such as Global Assessment of Functioning (GAF) and World Health Organization Disability Assessment Schedule (WHO-DAS)) showed moderate improvements [15, 24], while interventions focused on metabolic management, body composition, or cardiometabolic parameters presented more heterogeneous results [10, 18].

To enhance the interpretation of intervention effects, the results were additionally analyzed according to the type of control condition. Studies comparing SPEs with passive controls (e.g., waiting list conditions) generally demonstrated larger effect sizes, particularly in negative symptoms, global functioning, and cardiorespiratory fitness [16]. In contrast, studies using TAU as the control condition showed consistent, although more moderate, improvements, reflecting the additive effect of exercise to standard psychiatric care [8, 21, 23].

When compared to active non-exercise interventions (e.g., psychoeducation, cognitive training, or active video games), the effects of exercise were more heterogeneous, with some studies demonstrating superiority of exercise, particularly for physical fitness and specific cognitive domains, while others showed comparable outcomes between conditions [18, 19, 25]. This pattern suggests that part of the observed benefits may be influenced by engagement in structured activities, although exercise appears to provide additional physiological and neurocognitive advantages.

The risk of bias assessment revealed moderate methodological variability across the included trials. Six studies were classified as low risk of bias, while ten presented some concerns according to the RoB 2 criteria. The domains of randomization process and outcome measurement were generally rated as low risk or with some concerns. However, potential bias related to deviations from intended interventions and lack of blinding was frequently identified, which is expected in exercise-based interventions. These limitations should be considered when interpreting the magnitude and consistency of the reported effects [13, 14].

Discussion

The current study aimed to systematically synthesize the evidence from randomized clinical trials that investigated structured physical exercise programs in individuals with schizophrenia and the effects on psychiatric symptoms and other clinically relevant outcomes. Overall, the findings consistently indicate that structured physical exercise interventions can produce beneficial effects on core dimensions of the disorder, particularly negative symptoms, overall functioning, and cardiorespiratory fitness, with additional improvements observed in certain cognitive domains. Across the analyzed trials, reductions in PANSS and BPRS scores were frequently reported, supporting the hypothesis that physical exercise may influence neurobiological mechanisms associated with the pathophysiology of schizophrenia, as suggested by recent literature [17].

Stratification of control conditions contributed to a more nuanced interpretation of the findings. Studies employing passive controls (e.g., waiting lists) generally reported more pronounced improvements [16], whereas comparisons with TAU demonstrated consistent additional benefits of structured physical exercise, particularly for negative symptoms and physical fitness [8, 21, 23]. In contrast, when compared to active non-exercise interventions (e.g., psychoeducation or cognitive training), the effects were more heterogeneous [18, 19, 25], suggesting that engagement in structured activities may partially account for clinical improvements. However, physical exercise appears to confer additional neurobiological and physiological benefits, especially in cardiorespiratory fitness and specific cognitive domains [10, 17, 22, 24]. Overall, the type of control condition emerges as a key methodological factor in interpreting the effects of exercise interventions in schizophrenia.

Improvements in negative symptoms, as observed in studies such as those of Wang et al. [21], Kimhy et al. [22], and Curcic et al. [9] corroborate earlier meta-analytic evidence indicating that physical exercise is among the few non-pharmacological interventions capable of producing clinically meaningful effects in this domain. Reviews [2, 28] suggest that motivational and cognitive deficits may be partially responsive to interventions that enhance hippocampal connectivity, increase BDNF levels, and reduce inflammatory markers—mechanisms that were also reported in some of the trials included in this synthesis, such as by Kimhy et al. [22].

In the present review, longer-duration aerobic exercise interventions demonstrated positive effects not only on psychiatric symptoms but also on cardiorespiratory fitness, as evidenced by significant increases in VO2max or VO2peak in the studies by Brobakken et al. [10], Cheng et al. [23], and Tous-Espelosin et al. [17]. These findings are consistent with evidence reported by Suetani et al. [29] and Kimhy et al. [30], who identified reduced physical fitness as one of the strongest predictors of mortality and functional disability in individuals with schizophrenia. Therefore, by improving aerobic capacity, physical exercise simultaneously contributes to both psychiatric and medical outcomes.

Despite the predominance of beneficial effects, not all studies reported homogeneous responses. Andersen et al. [18], for example, observed no significant differences in mean VO2max between intervention and control groups, although nearly half of the participants allocated to HIIT achieved an individual clinically relevant response (≥5%). This interindividual variability, also described by Ross et al. [31], may reflect differences in disease stage, adherence rates, antipsychotic medication effects, comorbidities, or biological variability in responsiveness to exercise.

The heterogeneity observed across the included trials may be explained by several methodological and clinical factors. These include differences in exercise modalities (e.g., aerobic training, resistance training, HIIT, Tai Chi, and combined protocols), variations in intervention intensity and duration, distinct clinical settings (outpatient versus institutionalized populations), and heterogeneity in participant characteristics, such as illness duration, medication regimens, and baseline physical fitness. Additionally, the studies employed different outcome measures and assessment instruments, which may have contributed to variability in the magnitude and direction of the reported effects.

Combined exercise interventions, such as those integrating HIIT and resistance training, as reported by Tous-Espelosin et al. [17], also yielded promising results, particularly regarding improvements in physical fitness and maintenance of body composition. These findings align with the literature emphasizing that multicomponent exercise programs may potentiate synergistic effects through the integration of cardiovascular and muscular stimuli, thereby promoting greater neural and functional plasticity [32].

Another relevant aspect concerns the cognitive effects observed following exercise interventions. Studies by Kimhy et al. [22], Ryu et al. [24], and Lo et al. [25] reported improvements in executive functions, working memory, and sleep-dependent memory consolidation—domains that are consistently impaired in schizophrenia. These findings are supported by neurobiological evidence demonstrating that aerobic exercise can increase hippocampal volume, modulate frontoparietal networks, and promote BDNF-dependent neuroplasticity [33, 34].

Functional outcomes were also positively influenced by physical exercise interventions. Studies conducted by Strassnig et al. [35] and Maurus et al. [15] reported improvements in activities of daily living and global functioning, including increases in Global Assessment of Functioning (GAF) scores. These findings are particularly relevant, as global functioning represents a robust marker of autonomy and long-term prognosis in schizophrenia [36] and typically shows slower improvement than positive symptoms.

Importantly, low-intensity exercise programs, such as the intervention proposed by Kurebayashi et al. [20], also demonstrated beneficial effects, particularly on cognitive outcomes and length of hospital stay. These results suggest that even less vigorous exercise stimuli can yield clinically relevant benefits, in line with recent recommendations for psychiatric populations with limited exercise tolerance [37, 38].

Despite these positive results, methodological limitations were identified across the included trials, including substantial heterogeneity in the intervention protocols, variability in usual treatment across centers, lack of blinding in some studies, and heterogeneous outcome assessment instruments. These factors complicate direct comparisons between studies, as previously highlighted by Guo et al. [38], Shimada et al. [26], and Sisman et al. [39]. Despite these limitations, beneficial effects were consistently observed across different clinical contexts, including outpatient, inpatient, and community-based settings, reinforcing the overall robustness of the evidence.

Additionally, although most interventions lasted for between 8 and 12 weeks, sustained benefits were reported in the follow-up assessments in the studies by Wang et al. [21] and Bang-Kittilsen et al. [19]. This maintenance of effects suggests that physical exercise may function not only as an acute intervention but also as a longitudinal component of schizophrenia treatment, consistent with the integrated care models proposed by Suetani and Vancampfort [29].

The current review presents limitations inherent to both the topic and the available body of evidence. Chief among these is the substantial heterogeneity of exercise protocols, encompassing differences in modality, intensity, frequency, supervision, and duration, which precluded quantitative meta-analysis. Additional limitations include variability in control conditions and generally modest sample sizes, which restrict the generalizability of the findings.

Conversely, this review exhibits several methodological strengths. It exclusively included RCTs, the gold standard for intervention research, thereby enhancing internal validity. The literature search was comprehensive, prospectively structured, and conducted across multiple international databases over a ten-year period. Furthermore, the detailed characterization of exercise protocols and the integration of psychiatric, cognitive, and functional outcomes provide a more comprehensive clinical perspective than prior reviews, which often focused solely on symptom reduction.

Conclusions

The current review indicates that interventions of varying intensities and modalities can produce relevant clinical benefits, suggesting that physical exercise offers a range of possibilities, adaptable to the needs, abilities, and preferences of each patient. This flexibility is particularly important in schizophrenia, considering the psychosocial, motivational, and functional barriers frequently associated with the disorder. Thus, the results presented here support the incorporation of physical exercise programs into mental health services, both in outpatient and institutional settings, as an accessible, low-cost, and potentially transformative care strategy for the clinical course of the disease.

Finally, although the findings support the therapeutic potential of physical exercise, there is still a need for greater standardization of protocols, methodological improvements, and studies that explore the mechanisms involved in the identified effects, with greater precision. Future studies should explore characteristics that modulate the response to exercise (intensity, volume, adherence, interactions with pharmacological treatment, disease stage) and evaluate long-term outcomes, including, for example, social reintegration, quality of life, and autonomy. Even so, based on the current evidence, physical exercise emerges as a robust and multidimensional non-pharmacological intervention, capable of significantly contributing to the advancement of more integrated, humane, and effective clinical practices focused on the care and treatment of schizophrenia.

Availability of Data and Materials

All data generated or analyzed during this study are included in this published article.

Acknowledgment

The authors would like to thank the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior–Brasil (CAPES) for the financial support.

Supplementary Material

Supplementary material associated with this article can be found, in the online version, at https://doi.org/10.62641/aep.v54i3.2198.

Funding Statement

This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior–Brasil (CAPES), Finance Code 001.

Author Contributions

GBA designed the study, conducted the research, and drafted the manuscript. CAMN, BMM, and CJS contributed to data analysis and manuscript preparation. SEF and HSJ contributed to study design, data interpretation, and critical revision of the manuscript. All authors read and approved the final version of the manuscript and agree to be accountable for all aspects of the work.

Ethics Approval and Consent to Participate

Not applicable.

Funding

This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior–Brasil (CAPES), Finance Code 001.

Conflict of Interest

The authors declare no conflict of interest.

References

  • [1].Bergamin J, Luigjes J, Kiverstein J, Bockting CL, Denys D. Defining autonomy in psychiatry. Frontiers in Psychiatry . 2022;13:801415. doi: 10.3389/fpsyt.2022.801415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Firth J, Stubbs B, Rosenbaum S, Vancampfort D, Malchow B, et al. Aerobic exercise improves cognitive functioning in people with schizophrenia: a systematic review and meta-analysis. Schizophrenia Bulletin . 2017;43:546–556. doi: 10.1093/schbul/sbw115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Millan MJ, Fone K, Steckler T, Horan WP. Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment. European Neuropsychopharmacology . 2014;24:645–692. doi: 10.1016/j.euroneuro.2014.03.008. [DOI] [PubMed] [Google Scholar]
  • [4].Huhn M, Nikolakopoulou J, Scheider-Thoma J, Krause M, Samara M, Peter N, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia. a systematic review and network meta-analysis. The Lancet . 2019;394:939–951. doi: 10.1016/S0140-6736(19)31135-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [5].Vancampfort D, Rosenbaum S, Schuch F, Ward PB, Richards J, Mugisha J, et al. Cardiorespiratory Fitness in Severe Mental Illness: A Systematic Review and Meta-analysis. Sports Medicine . 2017;47:343–352. doi: 10.1007/s40279-016-0574-1. [DOI] [PubMed] [Google Scholar]
  • [6].Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public health reports . 1985;100:126–131. [PMC free article] [PubMed] [Google Scholar]
  • [7].Erickson KI, Hillman C, Stillman CM, Ballard RM, Bloodgood B, Conroy DE, et al. Physical Activity, Cognition, and Brain Outcomes: A Review of the 2018 Physical Activity Guidelines. Medicine and science in sports and exercise . 2019;51:1242–1251. doi: 10.1249/mss.0000000000001936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Silva BA, Cassilhas RC, Attux C, Cordeiro Q, Gadelha AL, Telles BA, et al. A 20-week program of resistance or concurrent exercise improves symptoms of schizophrenia: results of a blind, randomized controlled trial. Revista brasileira de psiquiatria . 2015;37:271–279. doi: 10.1590/1516-4446-2014-1595. [DOI] [PubMed] [Google Scholar]
  • [9].Curcic D, Stojmenovic T, Djukic-Dejanovic S, Dikic N, Vesic-Vukasinovic M, Radivojevic N, et al. Positive impact of prescribed physical activity on symptoms of schizophrenia. Psychiatria Danubina . 2017;29:459–465. doi: 10.24869/psyd.2017.459. [DOI] [PubMed] [Google Scholar]
  • [10].Brobakken MF, Nygård M, Güzey IC, Morken G, Reitan SK, Heggelund J, et al. Aerobic interval training in standard treatment of out-patients with schizophrenia. Acta Psychiatrica Scandinavica . 2019;140:498–507. doi: 10.1111/acps.13105. [DOI] [PubMed] [Google Scholar]
  • [11].Dauwan M, Begemann MJH, Heringa SM, Sommer IE. Exercise Improves Clinical Symptoms, Quality of Life, Global Functioning, and Depression in Schizophrenia: A Systematic Review and Meta-analysis. Schizophrenia Bulletin . 2016;42:588–599. doi: 10.1093/schbul/sbv164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed.) . 2021;372:n71. doi: 10.1136/bmj.n71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomized trials. BMJ (Clinical research ed.) . 2019;28:l4898. doi: 10.1136/bmj.l4898. [DOI] [PubMed] [Google Scholar]
  • [14].Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane Handbook for Systematic Reviews of Interventions . Cochrane; London, UK: 2022. 6.3 edn. [Google Scholar]
  • [15].Maurus I, Mantel C, Keller-Varady K, Schmitt A, Lembeck M, Röh A, et al. Resistance training in patients with schizophrenia. Journal of psychiatric research . 2020;120:72–82. doi: 10.1016/j.jpsychires.2019.09.015. [DOI] [PubMed] [Google Scholar]
  • [16].Ho RTH, Fong TCT, Wan AHY, Au-Yeung FSW, Wong CPK, Ng WYH, et al. A randomized controlled trial on the psychophysiological effects of physical exercise and Tai-chi in patients with chronic schizophrenia. Schizophrenia Research . 2016;171:42–49. doi: 10.1016/j.schres.2016.01.038. [DOI] [PubMed] [Google Scholar]
  • [17].Tous-Espelosin M, Ruiz De Azua S, Iriarte-Yoller N, Sanchez Pm, Elizagarate E, Maldonado-Martín S. As We Were and as We Should Be, Combined Exercise Training in Adults with Schizophrenia: CORTEX-SP Study Part I. Medicine and science in sports and exercise . 2024;56:73–81. doi: 10.1249/mss.0000000000003284. [DOI] [PubMed] [Google Scholar]
  • [18].Andersen E, Bang-Kittilsen G, Bigseth TT, Egeland J, Holmen TL, Martinsen EW, et al. Effect of high-intensity interval training on cardiorespiratory fitness, physical activity and body composition in people with schizophrenia: a randomized controlled trial. BMC psychiatry . 2020;20:425. doi: 10.1186/s12888-020-02827-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].Bang-Kittilsen G, Engh JA, Holst R, Holmen TL, Bigseth TT, Andersen E, et al. High-intensity interval training may reduce depressive symptoms in individuals with schizophrenia, putatively through improved VO2max: A randomized controlled trial. Frontiers in psychiatry . 2022;13:921689. doi: 10.3389/fpsyt.2022.921689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [20].Kurebayashi Y, Mori K, Otaki J. Effects of mild-intensity physical exercise on neurocognition in inpatients with schizophrenia: a pilot randomized controlled trial. Perspectives in psychiatric care . 2022;58:1037–1047. doi: 10.1111/ppc.12896. [DOI] [PubMed] [Google Scholar]
  • [21].Wang PW, Lin CH, Su CY, Chen MD, Lin KC, Ko CH, et al. Effect of Aerobic Exercise on Improving Symptoms of Individuals With Schizophrenia: A Single Blinded Randomized Control Study. Frontiers in psychiatry . 2018;9:167. doi: 10.3389/fpsyt.2018.00167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22].Kimhy D, Vakhrusheva J, Bartels MN, Armstrong HF, Ballon JS, Khan S, et al. The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial. Schizophrenia bulletin . 2015;41:859–868. doi: 10.1093/schbul/sbv022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Cheng S, Sun H, Yeh M. Effects of an 8-Week Aerobic Dance Program on Health-Related Fitness in Patients with Schizophrenia. The journal of nursing research . 2017;25:429–435. doi: 10.1097/jnr.0000000000000200. [DOI] [PubMed] [Google Scholar]
  • [24].Ryu J, Jung JH, Kim J, Kim C, Lee H, Kim D, et al. Outdoor cycling improves clinical symptoms, cognition and objectively measured physical activity in patients with schizophrenia: a randomized controlled trial. Journal of psychiatric research . 2020;120:144–153. doi: 10.1016/j.jpsychires.2019.10.015. [DOI] [PubMed] [Google Scholar]
  • [25].Lo LLH, Lee EHM, Hui CLM, Chong CSY, Chang WC, Chan SKW, et al. Effect of high-endurance exercise intervention on sleep-dependent procedural memory consolidation in individuals with schizophrenia: a randomized controlled trial. Psychological medicine . 2023;53:1708–1720. doi: 10.1017/s0033291721003196. [DOI] [PubMed] [Google Scholar]
  • [26].Shimada T, Ito S, Makabe A, Yamanushi A, Takenaka A, Kobayashi M. Aerobic exercise and cognitive functioning in schizophrenia: A pilot randomized controlled trial. Psychiatry research . 2019;282:112638. doi: 10.1016/j.psychres.2019.112638. [DOI] [PubMed] [Google Scholar]
  • [27].Khonsari NM, Badrfam R, Mohammdi MR, Rastad H, Etemadi F, Vafaei Z, et al. Effects of aerobic exercise on clinical outcomes in patients with schizophrenia: a randomized controlled trial. Journal of psychosocial nursing and mental health services . 2022;60:38–43. doi: 10.3928/02793695-20211014-03. [DOI] [PubMed] [Google Scholar]
  • [28].Firth J, Cotter J, Elliott R, French P, Yung AR. A systematic review and meta-analysis of exercise interventions in schizophrenia patients. Psychological medicine . 2015;45:1343–1361. doi: 10.1017/s0033291714003110. [DOI] [PubMed] [Google Scholar]
  • [29].Suetani S, Vancampfort D. Physical Exercise in the Management of Schizophrenia Spectrum Disorders. In: Noordsy DL, editor. Lifestyle Psychiatry . American Psychiatric Association Publishing; Washington, DC, USA: 2019. p. 93. [Google Scholar]
  • [30].Kimhy D, Tay C, Vakhrusheva J, Beck-Felts K, Ospina LH, Ifrah C, et al. Enhancement of aerobic fitness improves social functioning in individuals with schizophrenia. European archives of psychiatry and clinical neuroscience . 2021;271:367–376. doi: 10.1007/s00406-020-01220-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [31].Ross R, Goodpaster BH, Koch LG, Sarzynski MA, Kohrt WM, Johannsen NM, et al. Precision exercise medicine: understanding exercise response variability. British journal of sports medicine . 2019;53:1141–1153. doi: 10.1136/bjsports-2018-100328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [32].Ashdown-Franks G, Williams J, Vancampfort D, Firth J, Schuch F, Hubbard K, et al. Is it possible for people with severe mental illness to sit less and move more? A systematic review of interventions to increase physical activity or reduce sedentary behaviour. Schizophrenia research . 2018;202:3–16. doi: 10.1016/j.schres.2018.06.058. [DOI] [PubMed] [Google Scholar]
  • [33].Voss MW, Nagamatsu LS, Liu-Ambrose T, Kramer AF. Exercise, brain, and cognition across the life span. Journal of applied physiology . 2011;111:1505–1513. doi: 10.1152/japplphysiol.00210.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [34].Augusto-Oliveira M, Arrifano GP, Leal-Nazaré CG, Santos-Sacramento L, Lopes-Araújo A, Royes LFF, et al. Exercise Reshapes the Brain: Molecular, Cellular, and Structural Changes Associated with Cognitive Improvements. Molecular neurobiology . 2023;60:6950–6974. doi: 10.1007/s12035-023-03492-8. [DOI] [PubMed] [Google Scholar]
  • [35].Strassnig M, Bowie C, Pinkham AE, Penn D, Twamley EW, Patterson TL, et al. Which levels of cognitive impairments and negative symptoms are related to functional deficits in schizophrenia? Journal of psychiatric research . 2018;104:124–129. doi: 10.1016/j.jpsychires.2018.06.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [36].Rosenbaum S, Tiedemann A, Sherrington C, Curtis J, Ward PB. Physical activity interventions for people with mental illness: a systematic review and meta-analysis. The Journal of clinical psychiatry . 2014;75:964–974. doi: 10.4088/jcp.13r08765. [DOI] [PubMed] [Google Scholar]
  • [37].Gallardo-Gómez D, Noetel M, Álvarez-Barbosa F, Alfonso-Rosa RM, Ramos-Munell J, Del Pozo Cruz B, et al. Exercise to treat psychopathology and other clinical outcomes in schizophrenia: A systematic review and meta-analysis. European psychiatry: the journal of the Association of European Psychiatrists . 2023;66:e40. doi: 10.1192/j.eurpsy.2023.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [38].Guo J, Liu K, Liao Y, Qin Y, Yue W. Efficacy and feasibility of aerobic exercise interventions as an adjunctive treatment for patients with schizophrenia: a meta-Analysis. Schizophrenia (Heidelberg, Germany) . 2024;10:2. doi: 10.1038/s41537-023-00426-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [39].Sisman FN, Büber B, Taş F, Turan H. Randomized Controlled Trial for the Effects of an Exercise Program for Functional Remission and Weight Control in Schizophrenia: A Community Mental Health Study. Issues in mental health nursing . 2022;43:603–612. doi: 10.1080/01612840.2021.2024630. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

All data generated or analyzed during this study are included in this published article.


Articles from Actas Españolas de Psiquiatría are provided here courtesy of Fundación Juan José López-Ibor

RESOURCES